Вы находитесь на странице: 1из 12

Emkay FMCG Sector

Update
Sector
Research FMCG – Aberration or Trend?
March 19, 2009

The best defensive bet i.e. the consumer staple sector has been steadily sliding
HUL BUY down over the last few weeks. The global fall in consumer staple stocks started in
February with their Indian counterparts following with a slight lag. In international
Price Target Price markets, P&G (-16.8%), Diageo (-19.2%), ITC (-16.8%) & Colgate (-14.6%) under
Rs233 Rs305 performed the US market while McBride (-8.3%) and Croda (-16.8%) under
performed the European markets. European markets reported 8-10% decline while
Price Performance S&P registered 8.4% decline over the same period. Indian consumer staple sector
(%) 1M 3M 6M 12M
mirrored the global trend with a lag of 15 days. Consumer staple majors like HUL
(-15.3%) and ITC (-10.6%) and APL (-11.8%) reported sharp decline in stock prices
Absolute (9) (6) (2) 1 after 16th February 2009. The absence of any adverse news flow for the sector
Rel. to Sensex (6) 4 44 66 raises several questions - Is this temporary aberration? Or is this an early
indicator of a shift in trend from defensives to more lucrative options?

APL BUY Despite this, we reiterate our positive stance on the consumer staple sector and
expect the sector to report robust earnings growth accompanied with earning
Price Target Price surprises in next 2 quarters. In absence of incremental actions or news flow, we
Rs753 Rs1,000 do not view obstacles to the earnings performance for next 2 quarters. However,
we believe that the pricing actions and volume indications will be key reference
Price Performance points for the sector. We will closely monitor the general price actions and
volume indications for any change in earnings momentum for the sector. But, it is
(%) 1M 3M 6M 12M very unlikely that sector will witness de-rating in next 2 quarters despite any
Absolute (6) (13) (37) (34) unexpected change in earnings momentum.
Rel. to Sensex (3) (3) (7) 10
Key Financials: Rs Mn
GCPL ACCUM Hindustan Unilever Ltd.
Div
Net EBITDA AEPS EV/ Yld RoE
Price Target Price
YE-Mar
Sales (Core) (%) APAT (Rs) EBITDA P/BV (%) (%) P/E
Rs112 Rs127
CY2006 124,110 15,954 12.9 18936 6.8 25.7 19.6 2.7 62.8 34.2
Price Performance CY2007 139,134 19,033 13.7 19189 8.0 21.7 33.6 4.5 84.1 29.2
CY2008E 165,186 22,181 13.4 20253 9.3 18.7 29.9 3.6 126.3 25.1
(%) 1M 3M 6M 12M CY2009E 186,912 28,573 15.3 25567 11.7 14.9 26.1 4.6 140.5 19.8

Absolute (12) (3) (5) (14) Asian Paints Ltd.


Rel. to Sensex (9) 8 41 42 Div
Net EBITDA AEPS EV/ Yld RoE
YE-Mar
Sales (Core) (%) APAT (Rs) EBITDA P/BV (%) (%) P/E
MARICO ACCUM FY2007 36,700 4,856 13.2 2868 29.9 14.5 9.4 3.0 40.3 25.2
FY2008 44,043 6,598 15.0 4327 45.1 10.4 7.4 1.2 49.2 16.7
Price Target Price FY2009E 53,700 6,530 12.2 4162 43.4 10.5 5.6 1.2 36.6 17.4
FY2010E 58,693 7,529 12.8 4786 49.9 9.1 4.4 1.3 32.5 15.1
Rs62 Rs60
Godrej Consumer Products Ltd.
Price Performance
Div
Net EBITDA AEPS EV/ Yld RoE
(%) 1M 3M 6M 12M YE-Mar
Sales (Core) (%) APAT (Rs) EBITDA P/BV (%) (%) P/E
Absolute 5 16 7 (2) FY2007 9,515 1,800 18.9 1392 6.2 14.8 20.8 3.3 114.0 18.2
Rel. to Sensex 9 29 59 62 FY2008 11,040 2,229 20.2 1592 7.0 12.0 14.7 3.6 92.7 15.9
Source: Bloomberg FY2009E 13,691 1,901 13.9 1594 6.2 14.0 4.5 3.2 25.1 18.1
FY2010E 15,191 2,229 14.7 1886 7.3 11.5 4.0 3.8 26.4 15.3

Pritesh Chheda, CFA Marico Ltd.


pritesh.chheda@emkayshare.com Div
Net EBITDA AEPS EV/ RoCE
Yld
+91 22 6612 1273
YE-Mar Sales (Core) (%) APAT (Rs) EBITDA P/BV (%) (%) P/E
Sachin Bobade FY2007 15569 1990 12.8% 1129 1.9 20.0 19.6 1.1 24.4 33.5
sachin.bobade@emkayshare.com FY2008 19067 2380 12.5% 1692 2.8 17.1 12.0 1.1 32.7 22.3
FY2009E 22558 2859 12.7% 1853 3.0 13.9 8.3 1.2 30.1 20.4
+91 22 6624 2492
FY2010E 25602 3307 12.9% 2184 3.6 11.8 6.1 1.4 30.6 17.3

Emkay Research 19 March 2009 1


FMCG Sector Update

Croda International (Europe) declined 16.9% since Jan 30 2009

Diageo (Europe) declined 19.2% since Jan 30 2009

Emkay Research 19 March 2009 2


FMCG Sector Update

GlaxoSmithKline (Europe) declined 13.2% since Jan 30 2009

Henkel (Europe) declined 15.5% since Jan 30 2009

Emkay Research 19 March 2009 3


FMCG Sector Update

McBride (Europe) declined 8.3% since Jan 30 2009

Nestle (Europe) declined 8.2% since Jan 30 2009

Emkay Research 19 March 2009 4


FMCG Sector Update

Reckitt Benckiser (Europe) declined 2.6% since Jan 30 2009

Church & Dwight (US) declined 7.6% since Jan 30 2009

Emkay Research 19 March 2009 5


FMCG Sector Update

Colgate (US) declined 14.6% since Jan 30 2009

ITC (US) declined 16.8% since Jan 30 2009

Emkay Research 19 March 2009 6


FMCG Sector Update

P&G (US) declined 16.8% since Jan 30 2009

Phillip Morris (US) declined 6.4% since Jan 30 2009

Emkay Research 19 March 2009 7


FMCG Sector Update

Asian Paints (India) declined 8.2% since Jan 30 2009

Dabur (India) surged 4.2% since Jan 30 2009

Emkay Research 19 March 2009 8


FMCG Sector Update

GCPL (India) declined 8.4% since Jan 30 2009

GSK C H L (India) soared 0.5% since Jan 30 2009

Emkay Research 19 March 2009 9


FMCG Sector Update

HUL (India) declined 12.1% since Jan 30 2009

ITC (India) declined 8.0% since Jan 30 2009

Emkay Research 19 March 2009 10


FMCG Sector Update

Marico (India) surged 5.0% since Jan 30 2009

Nestle (India) soared 2.3% since Jan 30 2009

Emkay Research 19 March 2009 11


FMCG Sector Update

United Spirits (India) soared 7.1% since Jan 30 2009

Source: Bloomberg

DISCLAIMER: This document is not for public distribution and has been furnished to you solely for your information and may not be reproduced or redistributed to any other person. The manner
of circulation and distribution of this document may be restricted by law or regulation in certain countries, including the United States. Persons into whose possession this document may come are
required to inform themselves of, and to observe, such restrictions. This material is for the personal information of the authorized recipient, and we are not soliciting any action based upon it. This report
is not to be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. No person associated with Emkay Global
Financial Services Ltd. is obligated to call or initiate contact with you for the purposes of elaborating or following up on the information contained in this document. The material is based upon
information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon. Neither Emkay Global Financial Services Ltd., nor any person connected
with it, accepts any liability arising from the use of this document. The recipient of this material should rely on their own investigations and take their own professional advice. Opinions expressed are
our current opinions as of the date appearing on this material only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance,
or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.
We and our affiliates, officers, directors, and employees world wide, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in,
and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a
market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform investment banking services for such company(ies)or act as advisor or lender /
borrower to such company(ies) or have other potential conflict of interest with respect to any recommendation and related information and opinions. The same persons may have acted upon the
information contained here. No part of this material may be duplicated in any form and/or redistributed without Emkay Global Financial Services Ltd.'s prior written consent. No part of this document
may be distributed in Canada or used by private customers in the United Kingdom. In so far as this report includes current or historical information, it is believed to be reliable, although its accuracy and
completeness cannot be guaranteed.

Emkay Global Financial Services Ltd.


Paragon Center, H -13 -16, 1st Floor,
Pandurang Budhkar Marg, Worli, Mumbai – 400 013.
Tel no. 6612 1212. Fax: 6624 2410

Emkay Research 19 March 2009 12

Вам также может понравиться